Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Jalisco
Clinical trial register · Mexico

Clinical Trials in Jalisco, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:19 UTC
1585
Studies in scope
all four open statuses
704
Recruiting now
open to new participants
247
Lead sponsors
across recruiting studies
Top sites
Mexico City 600 Monterrey 378 Guadalajara 344 Chihuahua City 177 Mérida 128

Trials with a site in Jalisco

11 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Recruiting
Boehringer Ingelheim
Phase 3
448
Chihuahua City, Guadalajara, Jalisco, León, Mexico City, Tlalnepantla
2026-07-27
Recruiting
Boehringer Ingelheim
Phase 3
400
Jalisco, Mexico City, México, Monterrey
2026-01-16
Recruiting
Sanofi
Phase 3
980
Monterrey, Jalisco, Veracruz
2025-10-01
Recruiting
Summit Therapeutics
Phase 3
780
Aguascalientes, Guadalajara, Querétaro, Oaxaca City, Jalisco, Mexico City, Monterrey, Veracruz
2025-02-27
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Durango, Irapuato, Jalisco, Mexico City, Distrito Federal, Mérida, Morelia, Oaxaca City, Querétaro
2024-07-18
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Hoffmann-La Roche
Phase 3
1,800
Chihuahua City, Cuautitlán Izcalli, Cuernavaca, Jalisco, Mexico City, Mérida, Monterrey
2024-05-24
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Hoffmann-La Roche
Phase 3
1,350
Chihuahua City, Cuautitlán Izcalli, Jalisco, Mexico City, Morelos, Nuevo León, Yucatán
2024-03-13
Recruiting
Ipsen
Phase 3
276
Guadalajara, Jalisco, Mexico City, Monterrey, Yucatán
2023-08-31
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
565
Mexico City, Veracruz, Ver, Aguascalientes, Distrito Federal, Jalisco, San Luis de Potosi
2018-06-21
Recruiting
Octapharma
Observational
200
Jalisco, Morelia, Nuevo León
2018-02-13
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-mexico/city/jalisco

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 14 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Jalisco.

How many clinical trials are recruiting in Jalisco?

9 of the 11 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Jalisco), 11 studies
PhaseStudiesRecruitingShare
Phase 39781.8%
Observational119.1%
Phase 2119.1%

Most active sponsors

Lead sponsors with the most studies (Jalisco)
Lead sponsorStudiesRecruiting
Boehringer Ingelheim22
Hoffmann-La Roche22
Astellas Pharma Global Development, Inc.10
Genmab10
Ipsen11
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)11
Octapharma11
Sanofi11
Summit Therapeutics11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.